Business Services Industry

Biotechnology Winners Show Investors Big Potential.

Knight Ridder/Tribune Business News, November, 2003

By Ross Kerber, The Boston Globe Knight Ridder/Tribune Business News

Nov. 10--In the hot area of biotechnology investment, the chief recipients of venture capital in the third quarter would seem at first to have little in common.

For instance, the fund-raising leader in New England was GenPath Pharmaceuticals Inc. of Cambridge, which took in $42.7 million to develop genetic-based cancer therapies. Other recipients included Coley Pharmaceutical Group of Wellesley Hills, which produces drugs to bolster the immune system (it got $35 million), and OmniSonics Medical Technologies Inc. of Wilmington, which makes ultrasonic surgical devices (recipient of $26 million).

But some specialists do see a pattern in the rankings shown in the Money...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement